Cleveland Biolabs Inc (NASDAQ:CBLI)

3.38
Delayed Data
As of 3:59pm ET
 +0.09 / +2.74%
Today’s Change
3.07
Today|||52-Week Range
17.46
-40.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues15.3M8.8M3.6M8.5M
 
 
 
 
 
Depreciation And Amortization407.3K525.5K479.6K471.2K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.7M33.4M33.1M30.6M
 
 
 
 
 
Research And Development16.1M22.8M22.5M19.0M
 
 
 
 
 
Total Operating Expenses26.1M33.9M33.6M31.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-25.1M-30.0M-22.6M
 
 
 
 
 
Extraordinary Credit54.3K19.8M7.7M2.9M
 
 
 
 
 
Extraordinary Charge-16.0M0.000.00-506.2K
 
 
 
Pre-Tax Equity Earnings0.000.00407.4K217.3K
 
 
 
Interest Expense On Debt0.000.00477.4K134.2K
 
 
 
Other Expenses-76.3K-130.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.7M-5.2M-22.4M-20.1M
 
 
 
 
 
Minority Interest-305.8K-1.2M-4.2M-2.9M
 
 
 
 
 
Net Income-26.4M-4.0M-18.2M-17.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.3M1.6M1.9M2.3M
 
 
 
 
 
Shares To Calculate EPS Diluted1.3M1.6M1.9M2.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$20.20-$2.40-$9.80-$7.60
 
 
 
 
 
EPS Diluted-$20.20-$2.40-$9.80-$7.60
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account